Marta Guell-Duran
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
The linoleic acid-derived leukotoxin 9,10-DiHOME drives immunosuppression in patients with acute-on-chronic liver failure.
Journal: Hepatology (Baltimore, Md.)
Published: November 21, 2025
An optimized peritonitis-induced ACLF model that reproduces the full spectrum of extrahepatic organ failures in mice.
Journal: Hepatology communications
Published: February 07, 2025
Blood multiomics reveal a dysregulated lipid mediator-mitochondrial network associated with the outcome of advanced cirrhosis.
Journal: Nature communications
Published: December 10, 2024
Decompensated MASH-Cirrhosis Model by Acute and Toxic Effects of Phenobarbital.
Journal: Cells
Published: July 23, 2024
Palmitoylcarnitine impairs immunity in decompensated cirrhosis.
Journal: JHEP reports : innovation in hepatology
Published: December 30, 2023
Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction-associated fatty liver disease.
Journal: Hepatology (Baltimore, Md.)
Published: February 16, 2022
Small fragments of hyaluronan are increased in individuals with obesity and contribute to low-grade inflammation through TLR-mediated activation of innate immune cells.
Journal: International journal of obesity (2005)
Published: December 19, 2021
Albumin Lipidomics Reveals Meaningful Compositional Changes in Advanced Cirrhosis and Its Potential to Promote Inflammation Resolution.
Journal: Hepatology communications
Published: September 30, 2021
Mitochondrial Dysfunction in Advanced Liver Disease: Emerging Concepts.
Journal: Frontiers in molecular biosciences
Published: September 07, 2021
Proresolving lipid mediators and liver disease.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: January 29, 2021
Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure.
Journal: Journal of hepatology
Published: December 22, 2020
Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP/NF-κB/NLRP3 inflammasome circuit.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 27, 2020
Last Updated: 09/26/2026